| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Griffin Stephen D. | President and CEO, Director | C/O ANIKA THERAPEUTICS, INC., 32 WIGGINS AVENUE, BEDFORD | /s/ Stephen D. Griffin | 17 Mar 2026 | 0001831125 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIK | Common Stock | Options Exercise | +12,824 | +120% | 23,495 | 14 Mar 2026 | Direct | F1 | ||
| transaction | ANIK | Common Stock | Award | +6,412 | +27% | $0.000000* | 29,907 | 14 Mar 2026 | Direct | F2 | |
| transaction | ANIK | Common Stock | Tax liability | -5,944 | -20% | $14.20* | 23,963 | 14 Mar 2026 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ANIK | Restricted Stock Unit | Options Exercise | -12,824 | -33% | $0.000000* | 25,649 | 14 Mar 2026 | Common Stock | 12,824 | Direct | F1, F4 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock. |
| F2 | On March 14, 2025, the Reporting Person was granted 19,236 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award. |
| F3 | Reflects an aggregate of 5,944 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026. |
| F4 | On March 14, 2025, the Reporting Person was granted 38,473 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award. |